Publications by authors named "Estella Mendelson"

Claim this Profile
T
Treatment patterns and deep molecular response in chronic phase - chronic myeloid leukemia patients treated with second-line nilotinib or dasatinib: a multi-country retrospective chart review study.
Jorge Cortes, Lynn Huynh, Estella Mendelson, Patricia Brandt, Darshan Dalal

Leuk Lymphoma· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-free interval as a metric of patient experience and a health outcome of value for advanced multiple myeloma: the case for the histone deacetylase inhibitor panobinostat, a next-generation novel agent.
Paul Richardson, Anuja Roy, Suddhasatta Acharyya, Ashok Panneerselvam, Estella Mendelson

Expert Rev Hematol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with Ruxolitinib.
Keith L Davis, Isabelle Côté, James A Kaye, Estella Mendelson, Haitao Gao

Adv Hematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy.
Claire N Harrison, Ruben A Mesa, Jean-Jacques Kiladjian, Haifa-Kathrin Al-Ali, Heinz Gisslinger, Estella Mendelson

Br J Haematol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis